This study demonstrated that the percentage of GPC1+ plasma exosomes in total plasma exosomes measured one day before and one week after surgery was significantly higher in stage IIIC colon cancer patients than stage IIIA CRC patients. This evidence concerns the gene GPC1 and colorectal carcinoma.